Siemens Healthcare Diagnostics offers the LOCI® TPSA and FPSA assays for use on the Dimension Vista® 1500 System. The PSA assays employ LOCI® technology, a homogeneous, sandwich chemiluminescent immunoassay.

LOCI TPSA and FPSA assays consolidate tumor marker testing on a single platform. They offer precision for consistency in results reporting and accurate patient monitoring, dynamic assay ranges to limit need for sample dilutions, rapid assay kinetics to reduce TAT and provide better service levels to physicians and cancer patients anxiously awaiting results, and minimal sample volumes to eliminate sample splitting and simplify workflow.

Download a whitepaper to learn more about the Relevancy of PSA Testing.

Source: Press Release